TGA Approval

VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial (215523)

ARTG ID

215523

ARTG Name

VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial

Sponsor

BioMarin Pharmaceutical Australia Pty Ltd

ARTG Date

December 9, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BIOMARIN PHARMACEUTICAL AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/4ca3fd488210856795e5470ba8bd6485.pdf

https://medical-cdn.nocode.com/drug_tga/917e4762d8900f72e82bb675e03afe9a.pdf

Ingredient Name

elosulfase alfa

Empowering clinical research with data-driven insights and AI-powered tools.

VIMIZIM elosulfase alfa (rch) 1 mg/mL concentrated solution for injection vial (215523) - TGA 批准文号 | MedPath